Canada· CA-DIN-00568392
RIVA-OXAZEPAM
A oxazepam product containing oxazepam, registered in Canada by LABORATOIRE RIVA INC.. The same ATC class is registered in 14 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Oxazepam is registered in 14 of 19 countries.
Countries holding a registration under ATC N05BA04 (oxazepam), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 9 of them publish a price we can compare per daily dose
Oxazepam · ATC N05BA04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of oxazepam costs, country by country.
Normalised to the WHO defined daily dose (50 mg), the median price runs from $0.15 in France to $0.99 in Switzerland — a ×6.7 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Oxazepam · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.99
- FR France$0.15
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- OXAZEPAM
- Manufacturer
- LABORATOIRE RIVA INC.
- Country
- Canada (CA)
- ATC code
- N05BA04
- ATC class
- Oxazepam
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
277 interactions on record for oxazepam.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oxazepam · interactions on record
277 records
- 4 severe
- 70 moderate
- 22 minor
- 130 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
51 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Oxazepam in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomOxazepam 10mg tabletsAccord-UK Ltd
- NetherlandsOxazepam Accord 10 mg, tablettenAccord Healthcare B.V.
- FranceOXAZEPAM ARROW 10 mg, comprimé sécableARROW GENERIQUES
- SwedenDelipam 10 mg Tablett2care4 Generics ApS
- NorwayDelipam2care4 Generics ApS
- PolandOxazepam EspefaChemiczno-Farmaceutyczna Spółdzielnia Pracy ESPEFA
- CzechiaOXAZEPAM LÉČIVAZentiva, k.s., Praha
- IcelandSobrilPfizer ApS
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Anxiolit Forte, Praxiten
- Belgium · Oxazepam Eg
- Czechia · Oxazepam Léčiva
- Germany · Adumbran, Durazepam Forte
- Denmark · Oxabenz, Oxazepam Alternova
- Finland · Opamox, Oxamin
- France · Oxazepam Arrow, Oxazepam Biogaran
- United Kingdom (Northern Ireland) · Oxazepam Genus Pharmaceuticals, Oxazepam Tillomed Laboratories
- Croatia · Oksazepam Belupo, Praxiten
- Iceland · Sobril
- Italy · Serpax
- Lithuania · Nozepam, Tazepam
- Luxembourg · Oxazepam Eg
- Latvia · Nozepam, Tazepam
- Netherlands · Oxazepam Accord, Oxazepam Auro
- Norway · Delipam, Sobril
- Poland · Oksazepam Tzf, Oxazepam Espefa
- Portugal · Serenal
- Sweden · Delipam, Oxascand
- Slovenia · Oksazepam Belupo
- Slovakia · Oxazepam Léčiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b59dee61-8130-460e-bf97-795713645a79 GET /v1/drugs/b59dee61-8130-460e-bf97-795713645a79?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "00568392",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N05BA04",
"schedule": [
"Targeted (CDSA IV)"
],
"drug_code": "5563",
"strengths": [
"10 MG"
],
"ahfs_class": null,
"substances": [
"OXAZEPAM"
],
"product_categorization": null
}See everything about oxazepam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.